How Many Infusions of KRYSTEXXA Are Needed to Treat Gout?
KRYSTEXXA (pegloticase) is an FDA-approved medication for patients with chronic gout who have not responded adequately to other treatments. It works by breaking down uric acid, which is the root cause of gout symptoms when present in excess. The standard treatment plan for KRYSTEXXA involves an intravenous infusion, typically given every two weeks. Each infusion is administered over a period of approximately two hours, and the treatment is closely monitored by healthcare professionals to manage potential side effects and ensure the medication is working effectively.
The duration of treatment may vary based on individual response. Some patients experience significant improvements within the first few infusions, while others may require ongoing treatment for longer periods to maintain control of their gout symptoms. However, after an initial phase of regular infusions, a healthcare provider may adjust the treatment plan based on uric acid levels, symptoms, and other factors such as side effects. It's important for patients to attend follow-up appointments to ensure the treatment is working and to monitor for any adverse reactions.
